Epigenetic upregulation of Bak by ZBP-89 inhibits the growth of hepatocellular carcinoma.
Epigenetic upregulation of Bak by ZBP-89 inhibits the growth of hepatocellular carcinoma.
复制标题
DOI:
10.1016/j.bbamcr.2013.08.001
复制
发表时间:
2013-12
影响因子:
5.1
通讯作者:
Lai, Paul B. S.
中科院分区:
文献类型:
--
作者:
Ye, Cai Guo;Chen, George G.;Ho, Rocky L. K.;Merchant, Juanita L.;He, Ming-Liang;Lai, Paul B. S.
ZBP-89 regulates Bak to facilitate apoptosis in cancer cells. This study examined if ZBP-89 regulates Bak through an epigenetic mechanism in hepatocellular carcinoma (HCC). We first demonstrated that the expression of Bak was reduced but the levels of DNMT1 and HDAC3 were increased in HCC cancer tissues compared to the corresponding non-cancer tissues. Moreover, there was a negative correlation between Bak expression and DNMT1 levels in HCC. Administration of ZBP-89 downregulated HDAC3 expression and suppressed the activities of HDAC and DNMT, which led to maintenance of histone acetylation status, inhibited the binding of methyl-CpG-binding protein 2 to genomic DNA and demethylated CpG islands in the Bak promoter in HCC cells. Using the xenograft mouse tumor model, we demonstrated that ZBP-89 or inhibitors of either epigenetic enzymes could stimulate Bak expression, induce apoptosis, and arrest tumor growth and that the maximal effort was achieved when ZBP-89 and the enzyme inhibitors was used in combination. Conclusively, ZBP-89 upregulates the expression of Bak by targeting multiple components of the epigenetic pathway in HCC.
登录
查看更多内容
影响因子:
4
作者:
Hu, RG;Zhai, QW;Liu, XY
通讯作者:
Liu, XY
影响因子:
6.4
作者:
Miao, Ji;Chen, George G.;Lai, Paul B. S.
通讯作者:
Lai, Paul B. S.
影响因子:
5.4
作者:
Feng, Yunpeng;Wang, Xiuli;Lu, Jun
通讯作者:
Lu, Jun
影响因子:
30.8
作者:
Cameron, EE;Bachman, KE;Baylin, SB
通讯作者:
Baylin, SB
影响因子:
14.8
作者:
Lee, Tong Ihn;Johnstone, Sarah E.;Young, Richard A.
通讯作者:
Young, Richard A.